NCT06770296 2025-01-13
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
The First Affiliated Hospital with Nanjing Medical University
Phase 1 Recruiting
Clinical Trials
5 trialsNCT06290466 2024-03-04
Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects
Ahon Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT05352646 2023-09-28
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT01434849 2016-11-15
TiPPIH
The University of Texas Health Science Center at San Antonio
Phase 1 Terminated
NCT01304745 2013-07-09
Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study
Haukeland University Hospital
Phase 1 Unknown